Amarin Corp Plc (AMRN)

[ziploc_1]

Average ages in most countries are trending to be older...There are bound to be more patients ,needing care for acute and chronic diseases...As medical expenditures by governments become more restrictive, expensive medicines that extend lives for a few months or years, such as cancer therapies, will necessarily be made less available to patients by governments which pay the bills...and more available to patients with cardiovascular diseases, especially for less expensive medicines, which which extend lives for many more years.

Pfizer has chosen to pay $43 billion for Seagen's cancer drugs...rather than 4 billon for Amarin's Vascepa...This may not have been a good move at this point in time..even taking into account Pfizer's multiple upcoming patent expirations.